Researchers repurpose failed cancer drug into printable semiconductor

Researchers repurpose failed cancer drug into printable semiconductor
Chemical and biomolecular engineering professor Ying Diao and collaborators have repurposed a failed cancer drug into a new type of organic semiconductor for use in transistors and chemical sensors. Credit: L. Brian Stauffer

Many potential pharmaceuticals end up failing during clinical trials, but thanks to new research from the University of Illinois, biological molecules once considered for cancer treatment are now being repurposed as organic semiconductors for use in chemical sensors and transistors.

The researchers report their findings in the journal Nature Communications.

Organic semiconductors are responsible for things like flexible electronics and transparent solar cells, but researchers are working to expand their use in biomedicine and devices that require interaction between electrically and .

Chemical and biomolecular engineering professor Ying Diao said she was surprised when the two avenues of her research— and printable electronics—merged in her lab with the discovery of semiconductorlike features in a well-studied bioactive molecule. The molecule, which inserts itself into DNA to prevent replication, was once explored as a potential anti-cancer agent.

"This convergence of my two research areas was totally unexpected," Diao said. "While examining these pharmaceutical molecules, we noticed that their looked much like the organic semiconductors we were working with in the rest of my group."

These molecules, called DNA topoisomerase inhibitors, are flat and contain neatly stacked columns of electrically conductive molecular rings—features that make a good semiconductor. Distinct from a typical semiconductor, these molecular columns are linked together by that can move charges from column to column, forming bridges that transform the entire molecular assembly into a semiconductor—something rarely seen before this study, the researchers said.

"These molecules can interact with biological material with high specificity, making them good candidates for use in biosensors," Diao said. "They are also easily printable but will require new solvents because they are chemically different than other organic semiconductors. The fabrication infrastructure is already in place."

The team printed and tested the semiconductors and acknowledge that their efficiency and performance need improvement. Diao said the real excitement regarding this advance will come from the possibility of discovering similar molecules.

"We envision partnering with researchers in machine learning who can train computers to spot the unique characteristics of these molecules," Diao said. "They can mine the vast pharmaceutical databases available today in search of molecules with similar, or maybe even better semiconducting properties."


Explore further

Researchers develop dynamic templates critical to printable electronics technology

More information: Fengjiao Zhang et al, Repurposing DNA-binding agents as H-bonded organic semiconductors, Nature Communications (2019). DOI: 10.1038/s41467-019-12248-9
Journal information: Nature Communications

Citation: Researchers repurpose failed cancer drug into printable semiconductor (2019, October 2) retrieved 17 October 2019 from https://phys.org/news/2019-10-repurpose-cancer-drug-printable-semiconductor.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
252 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more